Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Prostate Cancer

  Free Subscription


12.08.2019

1 Acta Radiol
1 Anticancer Res
2 BJU Int
1 BMC Cancer
1 BMC Urol
1 Cancer
1 Eur Radiol
1 Eur Urol
1 Int J Cancer
4 Int J Radiat Oncol Biol Phys
4 J Urol
1 PLoS One
2 Prostate


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Radiol

  1. TULIPAN AJ, Hole KH, Vlatkovic L, Revheim ME, et al
    Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard.
    Acta Radiol. 2019;60:1028-1038.
    PubMed     Text format    


    Anticancer Res

  2. STANZIONE A, Ponsiglione A, Cuocolo R, Cocozza S, et al
    Abbreviated Protocols versus Multiparametric MRI for Assessment of Extraprostatic Extension in Prostatic Carcinoma: A Multireader Study.
    Anticancer Res. 2019;39:4449-4454.
    PubMed     Text format     Abstract available


    BJU Int

  3. HOU Y, Bao ML, Wu CJ, Zhang J, et al
    A Machine Learning-assisted Decision Support Model Can Better Spare Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    BJU Int. 2019 Aug 7. doi: 10.1111/bju.14892.
    PubMed     Text format     Abstract available

  4. SAKELLARIOU C, Elhage O, Papaevangelou E, Giustarini G, et al
    Prostate cancer cells enhance IL-15-mediated expansion of NK cells.
    BJU Int. 2019 Aug 7. doi: 10.1111/bju.14893.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. PUENTE J, Gonzalez-Del-Alba A, Sala-Gonzalez N, Mendez-Vidal MJ, et al
    Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO).
    BMC Cancer. 2019;19:766.
    PubMed     Text format     Abstract available


    BMC Urol

  6. BECKMANN K, Kinsella N, Olsson H, Wallerstedt Lantz A, et al
    Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
    BMC Urol. 2019;19:73.
    PubMed     Text format     Abstract available


    Cancer

  7. TABLAZON IL, Howard LE, De Hoedt AM, Aronson WJ, et al
    Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Cancer. 2019 Aug 7. doi: 10.1002/cncr.32414.
    PubMed     Text format     Abstract available


    Eur Radiol

  8. AHN H, Hwang SI, Lee HJ, Suh HS, et al
    Prediction of extraprostatic extension on multi-parametric magnetic resonance imaging in patients with anterior prostate cancer.
    Eur Radiol. 2019 Aug 5. pii: 10.1007/s00330-019-06340.
    PubMed     Text format     Abstract available


    Eur Urol

  9. THOMAS L, Baratchian M, Sharifi N
    Supraphysiologic Testosterone Solutions for Enzalutamide-resistant Prostate Cancer.
    Eur Urol. 2019 Jul 31. pii: S0302-2838(19)30596.
    PubMed     Text format    


    Int J Cancer

  10. LARSSON P, Syed Khaja AS, Semenas J, Wang T, et al
    The functional inter-link between AR and MMP9/VEGF signaling axis is mediated through PIP5K1alpha/pAKT in prostate cancer.
    Int J Cancer. 2019 Aug 5. doi: 10.1002/ijc.32607.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  11. LARGENT A, Barateau A, Nunes JC, Lafond C, et al
    Pseudo-CT Generation for MRI-Only Radiation Therapy Treatment Planning: Comparison Among Patch-Based, Atlas-Based, and Bulk Density Methods.
    Int J Radiat Oncol Biol Phys. 2019;103:479-490.
    PubMed     Text format     Abstract available

  12. MARVASO G, Ciardo D, Gandini S, Riva G, et al
    Comparison of outcomes and toxicity between extreme and moderate radiotherapy hypofractionation in localized prostate cancer: a propensity score analysis.
    Int J Radiat Oncol Biol Phys. 2019 Aug 1. pii: S0360-3016(19)33531.
    PubMed     Text format     Abstract available

  13. HERRERA FG, Valerio M, Berthold D, Tawadros T, et al
    50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
    Int J Radiat Oncol Biol Phys. 2019;103:320-334.
    PubMed     Text format     Abstract available

  14. MOUNTRIS KA, Visvikis D, Bert J
    DVH-Based Inverse Planning Using Monte Carlo Dosimetry for LDR Prostate Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2019;103:503-510.
    PubMed     Text format     Abstract available


    J Urol

  15. THOMPSON JE, Sridhar AN, Tan WS, Freeman A, et al
    Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound.
    J Urol. 2019;201:1134-1143.
    PubMed     Text format     Abstract available

  16. BUCKLEY RJ
    Re: Transperineal Prostate Biopsies Using Local Anesthesia: Experience with 1,287 Patients. Prostate Cancer Detection Rate, Complications and Patient Tolerability.
    J Urol. 2019 Aug 7:101097JU0000000000000473. doi: 10.1097/JU.0000000000000473.
    PubMed     Text format    

  17. DAL MORO F, Pizzolito S
    Re: Transperineal Prostate Biopsies Using Local Anesthesia: Experience with 1,287 Patients. Prostate Cancer Detection Rate, Complications and Patient Tolerability.
    J Urol. 2019 Aug 7:101097JU0000000000000474. doi: 10.1097/JU.0000000000000474.
    PubMed     Text format    

  18. XU L, Mao X, Grey A, Scandura G, et al
    Non-invasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells.
    J Urol. 2019 Aug 7:101097JU0000000000000475. doi: 10.1097/JU.0000000000000475.
    PubMed     Text format     Abstract available


    PLoS One

  19. BURNELL SEA, Spencer-Harty S, Howarth S, Bodger O, et al
    Utilisation of the STEAP protein family in a diagnostic setting may provide a more comprehensive prognosis of prostate cancer.
    PLoS One. 2019;14:e0220456.
    PubMed     Text format     Abstract available


    Prostate

  20. SHENDEROV E, Isaacsson Velho P, Awan AH, Wang H, et al
    Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype.
    Prostate. 2019 Aug 7. doi: 10.1002/pros.23881.
    PubMed     Text format     Abstract available

  21. WATANABE M, Kanao K, Suzuki S, Muramatsu H, et al
    Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis.
    Prostate. 2019 Aug 7. doi: 10.1002/pros.23890.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: